The pulmonary drugs are used for treating the conditions affecting lungs. The pulmonary drugs are used from treating minor illnesses such as the common cold to cure long-term disorders such asthma. These agents are available in different forms such as oral tablets, oral liquids, and injections or inhalations. Inhalations deliver the medicine directly to the lungs, which can act directly on the lung tissues, minimizing systemic side effects.
This report aims to provide a comprehensive presentation of the global market for Pulmonary Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pulmonary Drugs. This report contains market size and forecasts of Pulmonary Drugs in global, including the following market information:
Global Pulmonary Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Pulmonary Drugs Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Pulmonary Drugs companies in 2022 (%)
The global Pulmonary Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The major factors driving growth of the pulmonary drugs market include increasing incidence of chronic respiratory diseases, tobacco smoking, and government and non-government initiatives.
We surveyed the Pulmonary Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pulmonary Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Pulmonary Drugs Market Segment Percentages, by Type, 2022 (%)
Inhaled Corticosteroids
Long Acting Beta-2 Agonists
Antihistamines
Vasodilators
Others
Global Pulmonary Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Pulmonary Drugs Market Segment Percentages, by Application, 2022 (%)
Asthma & COPD
Allergic Rhinitis
Pulmonary Arterial Hypertension
Cystic Fibrosis
Others
Global Pulmonary Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Pulmonary Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pulmonary Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Pulmonary Drugs revenues share in global market, 2022 (%)
Key companies Pulmonary Drugs sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Pulmonary Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanofi SA
Meda Pharmaceuticals
Circassia Pharmaceuticals Plc.
AstraZeneca Plc.
GlaxoSmithKline Plc.
Mallinckrodt Pharmaceuticals Plc.
Cheisi Farmaceutici S.p.A
Zambon Company S.p.A
Alaxia SAS
Merck Sharp & Dohme Limited
Outline of Major Chapters:
Chapter 1: Introduces the definition of Pulmonary Drugs, market overview.
Chapter 2: Global Pulmonary Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Pulmonary Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Pulmonary Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Pulmonary Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Pulmonary Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Pulmonary Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Pulmonary Drugs Overall Market Size
2.1 Global Pulmonary Drugs Market Size: 2022 VS 2029
2.2 Global Pulmonary Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Pulmonary Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Pulmonary Drugs Players in Global Market
3.2 Top Global Pulmonary Drugs Companies Ranked by Revenue
3.3 Global Pulmonary Drugs Revenue by Companies
3.4 Global Pulmonary Drugs Sales by Companies
3.5 Global Pulmonary Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Pulmonary Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Pulmonary Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Pulmonary Drugs Players in Global Market
3.8.1 List of Global Tier 1 Pulmonary Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Pulmonary Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Pulmonary Drugs Market Size Markets, 2022 & 2029
4.1.2 Inhaled Corticosteroids
4.1.3 Long Acting Beta-2 Agonists
4.1.4 Antihistamines
4.1.5 Vasodilators
4.1.6 Others
4.2 By Type - Global Pulmonary Drugs Revenue & Forecasts
4.2.1 By Type - Global Pulmonary Drugs Revenue, 2018-2023
4.2.2 By Type - Global Pulmonary Drugs Revenue, 2024-2029
4.2.3 By Type - Global Pulmonary Drugs Revenue Market Share, 2018-2029
4.3 By Type - Global Pulmonary Drugs Sales & Forecasts
4.3.1 By Type - Global Pulmonary Drugs Sales, 2018-2023
4.3.2 By Type - Global Pulmonary Drugs Sales, 2024-2029
4.3.3 By Type - Global Pulmonary Drugs Sales Market Share, 2018-2029
4.4 By Type - Global Pulmonary Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Pulmonary Drugs Market Size, 2022 & 2029
5.1.2 Asthma & COPD
5.1.3 Allergic Rhinitis
5.1.4 Pulmonary Arterial Hypertension
5.1.5 Cystic Fibrosis
5.1.6 Others
5.2 By Application - Global Pulmonary Drugs Revenue & Forecasts
5.2.1 By Application - Global Pulmonary Drugs Revenue, 2018-2023
5.2.2 By Application - Global Pulmonary Drugs Revenue, 2024-2029
5.2.3 By Application - Global Pulmonary Drugs Revenue Market Share, 2018-2029
5.3 By Application - Global Pulmonary Drugs Sales & Forecasts
5.3.1 By Application - Global Pulmonary Drugs Sales, 2018-2023
5.3.2 By Application - Global Pulmonary Drugs Sales, 2024-2029
5.3.3 By Application - Global Pulmonary Drugs Sales Market Share, 2018-2029
5.4 By Application - Global Pulmonary Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Pulmonary Drugs Market Size, 2022 & 2029
6.2 By Region - Global Pulmonary Drugs Revenue & Forecasts
6.2.1 By Region - Global Pulmonary Drugs Revenue, 2018-2023
6.2.2 By Region - Global Pulmonary Drugs Revenue, 2024-2029
6.2.3 By Region - Global Pulmonary Drugs Revenue Market Share, 2018-2029
6.3 By Region - Global Pulmonary Drugs Sales & Forecasts
6.3.1 By Region - Global Pulmonary Drugs Sales, 2018-2023
6.3.2 By Region - Global Pulmonary Drugs Sales, 2024-2029
6.3.3 By Region - Global Pulmonary Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Pulmonary Drugs Revenue, 2018-2029
6.4.2 By Country - North America Pulmonary Drugs Sales, 2018-2029
6.4.3 US Pulmonary Drugs Market Size, 2018-2029
6.4.4 Canada Pulmonary Drugs Market Size, 2018-2029
6.4.5 Mexico Pulmonary Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Pulmonary Drugs Revenue, 2018-2029
6.5.2 By Country - Europe Pulmonary Drugs Sales, 2018-2029
6.5.3 Germany Pulmonary Drugs Market Size, 2018-2029
6.5.4 France Pulmonary Drugs Market Size, 2018-2029
6.5.5 U.K. Pulmonary Drugs Market Size, 2018-2029
6.5.6 Italy Pulmonary Drugs Market Size, 2018-2029
6.5.7 Russia Pulmonary Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Pulmonary Drugs Market Size, 2018-2029
6.5.9 Benelux Pulmonary Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Pulmonary Drugs Revenue, 2018-2029
6.6.2 By Region - Asia Pulmonary Drugs Sales, 2018-2029
6.6.3 China Pulmonary Drugs Market Size, 2018-2029
6.6.4 Japan Pulmonary Drugs Market Size, 2018-2029
6.6.5 South Korea Pulmonary Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Pulmonary Drugs Market Size, 2018-2029
6.6.7 India Pulmonary Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Pulmonary Drugs Revenue, 2018-2029
6.7.2 By Country - South America Pulmonary Drugs Sales, 2018-2029
6.7.3 Brazil Pulmonary Drugs Market Size, 2018-2029
6.7.4 Argentina Pulmonary Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Pulmonary Drugs Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Pulmonary Drugs Sales, 2018-2029
6.8.3 Turkey Pulmonary Drugs Market Size, 2018-2029
6.8.4 Israel Pulmonary Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Pulmonary Drugs Market Size, 2018-2029
6.8.6 UAE Pulmonary Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Sanofi SA
7.1.1 Sanofi SA Company Summary
7.1.2 Sanofi SA Business Overview
7.1.3 Sanofi SA Pulmonary Drugs Major Product Offerings
7.1.4 Sanofi SA Pulmonary Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Sanofi SA Key News & Latest Developments
7.2 Meda Pharmaceuticals
7.2.1 Meda Pharmaceuticals Company Summary
7.2.2 Meda Pharmaceuticals Business Overview
7.2.3 Meda Pharmaceuticals Pulmonary Drugs Major Product Offerings
7.2.4 Meda Pharmaceuticals Pulmonary Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Meda Pharmaceuticals Key News & Latest Developments
7.3 Circassia Pharmaceuticals Plc.
7.3.1 Circassia Pharmaceuticals Plc. Company Summary
7.3.2 Circassia Pharmaceuticals Plc. Business Overview
7.3.3 Circassia Pharmaceuticals Plc. Pulmonary Drugs Major Product Offerings
7.3.4 Circassia Pharmaceuticals Plc. Pulmonary Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Circassia Pharmaceuticals Plc. Key News & Latest Developments
7.4 AstraZeneca Plc.
7.4.1 AstraZeneca Plc. Company Summary
7.4.2 AstraZeneca Plc. Business Overview
7.4.3 AstraZeneca Plc. Pulmonary Drugs Major Product Offerings
7.4.4 AstraZeneca Plc. Pulmonary Drugs Sales and Revenue in Global (2018-2023)
7.4.5 AstraZeneca Plc. Key News & Latest Developments
7.5 GlaxoSmithKline Plc.
7.5.1 GlaxoSmithKline Plc. Company Summary
7.5.2 GlaxoSmithKline Plc. Business Overview
7.5.3 GlaxoSmithKline Plc. Pulmonary Drugs Major Product Offerings
7.5.4 GlaxoSmithKline Plc. Pulmonary Drugs Sales and Revenue in Global (2018-2023)
7.5.5 GlaxoSmithKline Plc. Key News & Latest Developments
7.6 Mallinckrodt Pharmaceuticals Plc.
7.6.1 Mallinckrodt Pharmaceuticals Plc. Company Summary
7.6.2 Mallinckrodt Pharmaceuticals Plc. Business Overview
7.6.3 Mallinckrodt Pharmaceuticals Plc. Pulmonary Drugs Major Product Offerings
7.6.4 Mallinckrodt Pharmaceuticals Plc. Pulmonary Drugs Sales and Revenue in Global (2018-2023)
7.6.5 Mallinckrodt Pharmaceuticals Plc. Key News & Latest Developments
7.7 Cheisi Farmaceutici S.p.A
7.7.1 Cheisi Farmaceutici S.p.A Company Summary
7.7.2 Cheisi Farmaceutici S.p.A Business Overview
7.7.3 Cheisi Farmaceutici S.p.A Pulmonary Drugs Major Product Offerings
7.7.4 Cheisi Farmaceutici S.p.A Pulmonary Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Cheisi Farmaceutici S.p.A Key News & Latest Developments
7.8 Zambon Company S.p.A
7.8.1 Zambon Company S.p.A Company Summary
7.8.2 Zambon Company S.p.A Business Overview
7.8.3 Zambon Company S.p.A Pulmonary Drugs Major Product Offerings
7.8.4 Zambon Company S.p.A Pulmonary Drugs Sales and Revenue in Global (2018-2023)
7.8.5 Zambon Company S.p.A Key News & Latest Developments
7.9 Alaxia SAS
7.9.1 Alaxia SAS Company Summary
7.9.2 Alaxia SAS Business Overview
7.9.3 Alaxia SAS Pulmonary Drugs Major Product Offerings
7.9.4 Alaxia SAS Pulmonary Drugs Sales and Revenue in Global (2018-2023)
7.9.5 Alaxia SAS Key News & Latest Developments
7.10 Merck Sharp & Dohme Limited
7.10.1 Merck Sharp & Dohme Limited Company Summary
7.10.2 Merck Sharp & Dohme Limited Business Overview
7.10.3 Merck Sharp & Dohme Limited Pulmonary Drugs Major Product Offerings
7.10.4 Merck Sharp & Dohme Limited Pulmonary Drugs Sales and Revenue in Global (2018-2023)
7.10.5 Merck Sharp & Dohme Limited Key News & Latest Developments
8 Global Pulmonary Drugs Production Capacity, Analysis
8.1 Global Pulmonary Drugs Production Capacity, 2018-2029
8.2 Pulmonary Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Pulmonary Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Pulmonary Drugs Supply Chain Analysis
10.1 Pulmonary Drugs Industry Value Chain
10.2 Pulmonary Drugs Upstream Market
10.3 Pulmonary Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Pulmonary Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Pulmonary Drugs in Global Market
Table 2. Top Pulmonary Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Pulmonary Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Pulmonary Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Pulmonary Drugs Sales by Companies, (K Units), 2018-2023
Table 6. Global Pulmonary Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Pulmonary Drugs Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Pulmonary Drugs Product Type
Table 9. List of Global Tier 1 Pulmonary Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Pulmonary Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Pulmonary Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Pulmonary Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Pulmonary Drugs Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Pulmonary Drugs Sales (K Units), 2018-2023
Table 15. By Type - Global Pulmonary Drugs Sales (K Units), 2024-2029
Table 16. By Application ? Global Pulmonary Drugs Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Pulmonary Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Pulmonary Drugs Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Pulmonary Drugs Sales (K Units), 2018-2023
Table 20. By Application - Global Pulmonary Drugs Sales (K Units), 2024-2029
Table 21. By Region ? Global Pulmonary Drugs Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Pulmonary Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Pulmonary Drugs Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Pulmonary Drugs Sales (K Units), 2018-2023
Table 25. By Region - Global Pulmonary Drugs Sales (K Units), 2024-2029
Table 26. By Country - North America Pulmonary Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Pulmonary Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Pulmonary Drugs Sales, (K Units), 2018-2023
Table 29. By Country - North America Pulmonary Drugs Sales, (K Units), 2024-2029
Table 30. By Country - Europe Pulmonary Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Pulmonary Drugs Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Pulmonary Drugs Sales, (K Units), 2018-2023
Table 33. By Country - Europe Pulmonary Drugs Sales, (K Units), 2024-2029
Table 34. By Region - Asia Pulmonary Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Pulmonary Drugs Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Pulmonary Drugs Sales, (K Units), 2018-2023
Table 37. By Region - Asia Pulmonary Drugs Sales, (K Units), 2024-2029
Table 38. By Country - South America Pulmonary Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Pulmonary Drugs Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Pulmonary Drugs Sales, (K Units), 2018-2023
Table 41. By Country - South America Pulmonary Drugs Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Pulmonary Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Pulmonary Drugs Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Pulmonary Drugs Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Pulmonary Drugs Sales, (K Units), 2024-2029
Table 46. Sanofi SA Company Summary
Table 47. Sanofi SA Pulmonary Drugs Product Offerings
Table 48. Sanofi SA Pulmonary Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Sanofi SA Key News & Latest Developments
Table 50. Meda Pharmaceuticals Company Summary
Table 51. Meda Pharmaceuticals Pulmonary Drugs Product Offerings
Table 52. Meda Pharmaceuticals Pulmonary Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Meda Pharmaceuticals Key News & Latest Developments
Table 54. Circassia Pharmaceuticals Plc. Company Summary
Table 55. Circassia Pharmaceuticals Plc. Pulmonary Drugs Product Offerings
Table 56. Circassia Pharmaceuticals Plc. Pulmonary Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. Circassia Pharmaceuticals Plc. Key News & Latest Developments
Table 58. AstraZeneca Plc. Company Summary
Table 59. AstraZeneca Plc. Pulmonary Drugs Product Offerings
Table 60. AstraZeneca Plc. Pulmonary Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. AstraZeneca Plc. Key News & Latest Developments
Table 62. GlaxoSmithKline Plc. Company Summary
Table 63. GlaxoSmithKline Plc. Pulmonary Drugs Product Offerings
Table 64. GlaxoSmithKline Plc. Pulmonary Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. GlaxoSmithKline Plc. Key News & Latest Developments
Table 66. Mallinckrodt Pharmaceuticals Plc. Company Summary
Table 67. Mallinckrodt Pharmaceuticals Plc. Pulmonary Drugs Product Offerings
Table 68. Mallinckrodt Pharmaceuticals Plc. Pulmonary Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. Mallinckrodt Pharmaceuticals Plc. Key News & Latest Developments
Table 70. Cheisi Farmaceutici S.p.A Company Summary
Table 71. Cheisi Farmaceutici S.p.A Pulmonary Drugs Product Offerings
Table 72. Cheisi Farmaceutici S.p.A Pulmonary Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. Cheisi Farmaceutici S.p.A Key News & Latest Developments
Table 74. Zambon Company S.p.A Company Summary
Table 75. Zambon Company S.p.A Pulmonary Drugs Product Offerings
Table 76. Zambon Company S.p.A Pulmonary Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 77. Zambon Company S.p.A Key News & Latest Developments
Table 78. Alaxia SAS Company Summary
Table 79. Alaxia SAS Pulmonary Drugs Product Offerings
Table 80. Alaxia SAS Pulmonary Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 81. Alaxia SAS Key News & Latest Developments
Table 82. Merck Sharp & Dohme Limited Company Summary
Table 83. Merck Sharp & Dohme Limited Pulmonary Drugs Product Offerings
Table 84. Merck Sharp & Dohme Limited Pulmonary Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 85. Merck Sharp & Dohme Limited Key News & Latest Developments
Table 86. Pulmonary Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 87. Global Pulmonary Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 88. Global Pulmonary Drugs Production by Region, 2018-2023 (K Units)
Table 89. Global Pulmonary Drugs Production by Region, 2024-2029 (K Units)
Table 90. Pulmonary Drugs Market Opportunities & Trends in Global Market
Table 91. Pulmonary Drugs Market Drivers in Global Market
Table 92. Pulmonary Drugs Market Restraints in Global Market
Table 93. Pulmonary Drugs Raw Materials
Table 94. Pulmonary Drugs Raw Materials Suppliers in Global Market
Table 95. Typical Pulmonary Drugs Downstream
Table 96. Pulmonary Drugs Downstream Clients in Global Market
Table 97. Pulmonary Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Pulmonary Drugs Segment by Type in 2022
Figure 2. Pulmonary Drugs Segment by Application in 2022
Figure 3. Global Pulmonary Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Pulmonary Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Pulmonary Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. Pulmonary Drugs Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Pulmonary Drugs Revenue in 2022
Figure 9. By Type - Global Pulmonary Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Pulmonary Drugs Revenue Market Share, 2018-2029
Figure 11. By Type - Global Pulmonary Drugs Sales Market Share, 2018-2029
Figure 12. By Type - Global Pulmonary Drugs Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Pulmonary Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Pulmonary Drugs Revenue Market Share, 2018-2029
Figure 15. By Application - Global Pulmonary Drugs Sales Market Share, 2018-2029
Figure 16. By Application - Global Pulmonary Drugs Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Pulmonary Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Pulmonary Drugs Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Pulmonary Drugs Revenue Market Share, 2018-2029
Figure 20. By Region - Global Pulmonary Drugs Sales Market Share, 2018-2029
Figure 21. By Country - North America Pulmonary Drugs Revenue Market Share, 2018-2029
Figure 22. By Country - North America Pulmonary Drugs Sales Market Share, 2018-2029
Figure 23. US Pulmonary Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Pulmonary Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Pulmonary Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Pulmonary Drugs Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Pulmonary Drugs Sales Market Share, 2018-2029
Figure 28. Germany Pulmonary Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. France Pulmonary Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Pulmonary Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Pulmonary Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Pulmonary Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Pulmonary Drugs Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Pulmonary Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Pulmonary Drugs Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Pulmonary Drugs Sales Market Share, 2018-2029
Figure 37. China Pulmonary Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Pulmonary Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Pulmonary Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Pulmonary Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. India Pulmonary Drugs Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Pulmonary Drugs Revenue Market Share, 2018-2029
Figure 43. By Country - South America Pulmonary Drugs Sales Market Share, 2018-2029
Figure 44. Brazil Pulmonary Drugs Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Pulmonary Drugs Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Pulmonary Drugs Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Pulmonary Drugs Sales Market Share, 2018-2029
Figure 48. Turkey Pulmonary Drugs Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Pulmonary Drugs Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Pulmonary Drugs Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Pulmonary Drugs Revenue, (US$, Mn), 2018-2029
Figure 52. Global Pulmonary Drugs Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Pulmonary Drugs by Region, 2022 VS 2029
Figure 54. Pulmonary Drugs Industry Value Chain
Figure 55. Marketing Channels
